HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $24

Benzinga Newsdesk www.benzinga.com Positive 72.7%

Neg 0% Neu 0% Pos 72.7%

HC Wainwright & Co. analyst Andrew S. Fein maintains Aura Biosciences (NASDAQ:AURA) with a Buy and raises the price target from $22 to $24.